Skip to main content
Tina Bhutani, MD, Dermatology, San Francisco, CA

TinaBhutaniMD, MAS

Dermatology San Francisco, CA

Owner and CEO, Synergy Dermatology; Associate Clinical Professor, UCSF Dermatology

Dr. Bhutani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bhutani's full profile

Already have an account?

  • Office

    595 Buckingham Way
    Ste 220
    San Francisco, CA 94132
    Phone+1 415-333-0348

Summary

  • Dr. Tina Bhutani is a board certified dermatologist and clinical researcher practicing in San Francisco, California where she is the CEO of Synergy Dermatology. She received her medical training at the University of Southern California Keck School of Medicine and completed her residency in dermatology at UCSF. Dr. Bhutani has an expertise in the treatment of psoriasis, atopic dermatitis, and other inflammatory skin diseases. In addition to seeing patients, she is an Associate Clinical Professor in the Department of Dermatology at UCSF. She is passionate about improving the care and lives of patients with inflammatory skin disorders and is involved in many studies focusing on the development of new treatments for these diseases and learning more about mechanisms of disease initiation and maintenance. She has a particular interest in the impact of disease on patient quality of life and mental health as well as the use of wellness-based behavior modification to improve disease severity and reduce the risk of associated comorbidities. She has published over 150 articles in peer-reviewed journals and has spoken at national and international conferences on these topics. She is a member of the National Psoriasis Foundation (NPF) Scientific Advisory committee and Medical Advisory Board. She has also received research grant funding from the NPF, the Dermatology Foundation, as well as Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She serves as the current editor-in-chief for the journal Psoriasis: Targets and Therapy.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Chief Residency, Dermatology, 2014 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Dermatology, 2012 - 2015
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterInternship, Preliminary Year, 2008 - 2009
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2008
  • University of California
    University of CaliforniaBS, Animal Physiology & Neuroscience, 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • National Psoriasis Foundation Medical Dermatology Research Grant Recipient 2012
  • Dean’s Recognition Keck School of Medicine, 2008
  • Scholarship for Academic Excellence Keck School of Medicine, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Impact of Pediatric Atopic Dermatitis on Families: A Review  
    John Koo, Tina Bhutani, Pediatric Dermatology
  • Dupilumab Treatment for Generalized Prurigo Nodularis  
    Tina Bhutani, Wilson Liao, JAMA
  • Recent Developments in Atopic Dermatitis  
    Sahil Sekhon, Tina Bhutani, AAP News
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Safe and Effective Treatment of Moderate to Severe Psoriasis using 308nm Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.
    Bhutani T, The Photomedicine Society 20th Annual Meeting, New Orleans, LA
  • Anatomically Differentiated Dosimetry for Optimal Phototherapy of Generalized Psoriasis.
    Bhutani T, The American Academy of Dermatology Summer Academy Meeting 2011., New York, New York
  • Innovative Treatment Option for Moderate-to-Severe Generalized Plaque Psoriasis Using 308nm-UVB Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.
    Heller MM, Lee ES, Kamangar F, Park K, Bhutani T, and Koo JYM, European Society for Dermatological Research’s 41st Annual Meeting, Barcelona, Spain
  • Join now to see all

Lectures

  • Phototherapy 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
  • A Pilot Study Evaluating the Efficacy of Intra-Lesional Amevive. 
    Tokyo, Japan. Astellas Headquarters
  • Modern Ultra Goeckerman Therapy. 
    Kasturba Medical College, Manipal, India

Other

Authored Content

  • Recent Developments in Atopic DermatitisSeptember 2018

Press Mentions

  • Megan Mosca on the Impact of Systemic Psoriasis Tx on Cardiometabolic Comorbidities
    Megan Mosca on the Impact of Systemic Psoriasis Tx on Cardiometabolic ComorbiditiesDecember 17th, 2021
  • STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call Transcript
    STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call TranscriptMay 12th, 2020
  • Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for Psoriasis
    Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for PsoriasisMarch 6th, 2019
  • Join now to see all